Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Non-Current Assets: 2015-2019

Historic Other Non-Current Assets for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $457,476.

  • Outlook Therapeutics' Other Non-Current Assets rose 196.51% to $1.4 million in Q2 2020 from the same period last year, while for Jun 2020 it was $1.4 million, marking a year-over-year increase of 196.51%. This contributed to the annual value of $457,476 for FY2019, which is 6.84% down from last year.
  • Outlook Therapeutics' Other Non-Current Assets amounted to $457,476 in FY2019, which was down 6.84% from $491,039 recorded in FY2018.
  • Outlook Therapeutics' Other Non-Current Assets' 5-year high stood at $960,563 during FY2015, with a 5-year trough of $457,476 in FY2019.
  • In the last 3 years, Outlook Therapeutics' Other Non-Current Assets had a median value of $491,039 in 2018 and averaged $562,959.
  • Data for Outlook Therapeutics' Other Non-Current Assets shows a maximum YoY slumped of 33.68% (in 2018) over the last 5 years.
  • Outlook Therapeutics' Other Non-Current Assets (Yearly) stood at $960,563 in 2015, then decreased by 11.22% to $852,801 in 2016, then dropped by 13.18% to $740,362 in 2017, then slumped by 33.68% to $491,039 in 2018, then decreased by 6.84% to $457,476 in 2019.